A federal appeals court on Thursday shut down AstraZeneca’s challenge to the U.S. government’s program that gives the ...

By Alistair Smout, Andrew MacAskill and Andrea Shalal LONDON/WASHINGTON (Reuters) -U.S. President Donald Trump and British ...

The pound edged up on Thursday while British stocks struggled to find a foothold after U.S. President Donald Trump and UK ...

Two new RCTs of rituximab will soon begin in the United Kingdom: A biomarker-based trial with add-on belimumab and another in ...

Afatinib has broad activity against EGFR mutations. However, the approval for uncommon mutations was based on data from 38 ...

AstraZeneca and Daiichi's Enhertu, followed by THP, has shown pCR rate improvement in the randomised DESTINY-Breast11 Phase ...

The AstraZeneca share price has pulled back in recent months. Dr James Fox explores how the stock compares with pharma peer GSK. The post Does the GSK or AstraZeneca share price currently offer the ...

The medicine, Trastuzumab deruxtecan, was already available for some breast and stomach cancers. It has been approved to ...

US President Donald Trump today hailed a 'great' trade deal that will "open up" the UK. And it will. Like an oyster.

A panel at OCT Europe touched upon where the European clinical trial industry is headed and the impact of technology and ...

Breztri Aerosphere, a triple inhaled therapy, met its primary endpoint of lung function improvement in adults and adolescents with uncontrolled asthma in two phase 3 trials, according to a press ...

Regardless of the macroeconomic environment, we remain focused on applying our well-established, long-term, bottom-up EQV ...